Introduction- Coxiella burnetii is the etiologic agent of Q fever, a potential bioweapon and select agent, andone of the most infectious pathogens known. However, there are few reports concerning this obligateintracellular agent's molecular pathogenesis or developmental cycle, and lack of a system for site-directedgenetic manipulation has severely hampered research progress. To address this dearth of information and toimprove the current state of molecular biology technology, we propose to: 1) examine the expression profilesof small cell variants (SCVs) and large cell variants (LCVs) of the developmental cycle to identify genes andproteins that allow Coxiella to survive for extended periods of time in the environment (SCV stage) and tosubsequently grow in the inhospitable confines of the host cell phagolysosome (LCV stage); 2) analyze andcompare expression profiles of in vitro versus in vivo-cultivated Coxiella and phase I versus phase IIorganisms to identify potential virulence determinants, and 3) develop a system of site-directed mutagenesisfor this organism to allow for the routine genetic manipulation and future development of an attenuatedvaccine strain. These data are expected to provide valuable information on the life cycle of Coxiella and therespective genes and proteins involved, and should lead to strategies for disrupting cellular development tocontrol Q fever. Finally, a system for routine genetic manipulation of Coxiella is an essential molecularbiology tool for examining suspected virulence genes and performing molecular Koch's postulates in vivo.Project Interactions- Project 3 (Harmsen) will interact with Project 1 (this study) as it relates to in vivocultivatedCoxiella from the mouse model. Projects 4 (Pascual) and 2 (Jutila) will benefit from Project 1 dataon stage-specific gene products; SCV-specific genes / antigens are hypothesized to be involved intransmission / early infection and LCV-specific genes / antigens are involved in intracellular replication.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54AI065357-04
Application #
7641034
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2008-05-01
Project End
2009-04-30
Budget Start
2008-05-01
Budget End
2009-04-30
Support Year
4
Fiscal Year
2008
Total Cost
$701,535
Indirect Cost
Name
Colorado State University-Fort Collins
Department
Type
DUNS #
785979618
City
Fort Collins
State
CO
Country
United States
Zip Code
80523
Webb, Jessica R; Price, Erin P; Somprasong, Nawarat et al. (2018) Development and validation of a triplex quantitative real-time PCR assay to detect efflux pump-mediated antibiotic resistance in Burkholderia pseudomallei. Future Microbiol 13:1403-1418
York, Joanne; Nunberg, Jack H (2018) A Cell-Cell Fusion Assay to Assess Arenavirus Envelope Glycoprotein Membrane-Fusion Activity. Methods Mol Biol 1604:157-167
Rhodes, Katherine A; Somprasong, Nawarat; Podnecky, Nicole L et al. (2018) Molecular determinants of Burkholderia pseudomallei BpeEF-OprC efflux pump expression. Microbiology 164:1156-1167
Cummings, Jason E; Slayden, Richard A (2017) Transient In Vivo Resistance Mechanisms of Burkholderia pseudomallei to Ceftazidime and Molecular Markers for Monitoring Treatment Response. PLoS Negl Trop Dis 11:e0005209
Pettey, W B P; Carter, M E; Toth, D J A et al. (2017) Constructing Ebola transmission chains from West Africa and estimating model parameters using internet sources. Epidemiol Infect 145:1993-2002
Furuta, Yousuke; Komeno, Takashi; Nakamura, Takaaki (2017) Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci 93:449-463
Skyberg, Jerod A; Lacey, Carolyn A (2017) Hematopoietic MyD88 and IL-18 are essential for IFN-?-dependent restriction of type A Francisella tularensis infection. J Leukoc Biol 102:1441-1450
Plumley, Brooke A; Martin, Kevin H; Borlee, Grace I et al. (2017) Thermoregulation of Biofilm Formation in Burkholderia pseudomallei Is Disrupted by Mutation of a Putative Diguanylate Cyclase. J Bacteriol 199:
Randall, Linnell B; Georgi, Enrico; Genzel, Gelimer H et al. (2017) Finafloxacin overcomes Burkholderia pseudomallei efflux-mediated fluoroquinolone resistance. J Antimicrob Chemother 72:1258-1260
Podnecky, Nicole L; Rhodes, Katherine A; Mima, Takehiko et al. (2017) Mechanisms of Resistance to Folate Pathway Inhibitors in Burkholderia pseudomallei: Deviation from the Norm. MBio 8:

Showing the most recent 10 out of 258 publications